Patents by Inventor David Dickason

David Dickason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR TREATING ACNE
    Publication number: 20220331269
    Abstract: A topical pharmaceutical composition comprising a solution of 2-(2-ethoxyethoxy)ethanol in a first solvent that is a 2-(2-ethoxyethoxy)ethanol solvent.
    Type: Application
    Filed: July 1, 2022
    Publication date: October 20, 2022
    Inventors: Eugene R. Cooper, Matthew Callahan, Michael Thurn, David Dickason
  • COMPOSITIONS FOR TREATING ACNE
    Publication number: 20200022927
    Abstract: A topical pharmaceutical composition comprising a solution of 2-(2-ethoxyethoxy)ethanol in a first solvent that is a 2-(2-ethoxyethoxy)ethanol solvent.
    Type: Application
    Filed: February 14, 2018
    Publication date: January 23, 2020
    Inventors: Eugene R. Cooper, Matthew Callahan, Michael Thurn, David Dickason
  • Preparation of microparticles having improved flow ability
    Publication number: 20070260038
    Abstract: Methods for preparing microparticles having improved flowability to facilitate processing in automated equipment. Microparticles are conditioned so that a flowability index of the microparticles is greater than about 60. The conditioning preferably includes maintaining the microparticles at a conditioning temperature for a period of time. The conditioning can be used with microparticles containing an active agent, and with placebo microparticles, and it is reversible.
    Type: Application
    Filed: June 21, 2007
    Publication date: November 8, 2007
    Applicant: Alkermes, Inc.
    Inventors: J. Michael Ramstack, Steven Wright, David Dickason
  • Polymorphic forms of naltrexone
    Publication number: 20060142320
    Abstract: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
    Type: Application
    Filed: June 3, 2004
    Publication date: June 29, 2006
    Applicant: Alkermes Controlled Therapeutics II
    Inventors: Harry Brittain, David Dickason, Joyce Hotz, Shawn Lyons, J. Ramstack, Steven Wright